For many years scientists have been focusing on finding non invasive ways to locate the “holy grail” of Alzheimer’s Disease (or what I have referred to as “amyloid associated memory impairment, AAMI). Perhaps finally we have arrived. Please read below:
Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir?
13 July 2010. [...]
Promise Seen for Detection of Alzheimer’s
I have been blogging quite often on the topic of “amyloid” buildup in the brains of patients with Alzheimer’s Disease and for those who have no memory loss (yet) but with amyloid detected in the brain. What good is it to know you might ask, that this sticky/gooey material [...]
Below is an excerpt from arguably one of the leading experts in the field of MCI. The sooner we seek treatment for memory loss, the better the outcome.
Mild cognitive impairment: A way station along road to Alzheimer’s
By Angela Lunde
(Ronald Petersen, M.D., Ph.D., is the director of the Mayo Clinic Alzheimer’s Disease Research Center. Below [...]
Many of my patients take Gingko despite no FDA approval for this supplement.
Many studies have shown convincingly it is worthless to take as well as expensive. Now another study is published which claims to have a huge protective effect compared to placebo in a four year followup of 2584 patients with “memory loss”. [...]
I have attached a copy of a section covering current treatments for AD reprinted from the following article:
My take on this approach is as follows: Similar to Baxter’s approach using their “Gamma Guard” it will take time to determine if this approach is truly meaningful to patients.
AMYLOID-TARGETED THERAPEUTICS IN ALZHEIMER’S DISEASE: USE OF HUMAN ALBUMIN [...]